Leap Therapeutics Inc. buy BiotechBee
Start price
07.01.24
/
50%
€3.70
Target price
30.09.25
€5.00
Performance (%)
-27.03%
End price
14.12.24
€2.70
Summary
This prediction ended on 14.12.24 with a price of €2.70. The price of Leap Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -27.03%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Leap Therapeutics Inc. | -12.710% | -12.710% | 144.295% |
| iShares Core DAX® | 0.789% | 1.975% | 13.390% |
| iShares Nasdaq 100 | 4.226% | 4.344% | 39.717% |
| iShares Nikkei 225® | 3.285% | 6.991% | 49.894% |
| iShares S&P 500 | 2.496% | 2.759% | 30.229% |
According to BiotechBee what are the pros and cons of Leap Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year